MétaCan
Menu
Back to cohort
Record W4387799247 · doi:10.1002/ajh.27134

Lung function decline in children with sickle cell disease treated with hydroxyurea

2023· letter· en· W4387799247 on OpenAlexaffabout
Elias Seidl, David C. Wilson, Isaac Odame, Melanie Kirby‐Allen, Hartmut Grasemann

Bibliographic record

VenueAmerican Journal of Hematology · 2023
Typeletter
Languageen
FieldMedicine
TopicHemoglobinopathies and Related Disorders
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsMedicineLung functionDiseaseSickle cell anemiaIntensive care medicinePediatricsLungInternal medicine

Abstract

fetched live from OpenAlex

To the Editor: Sickle cell disease (SCD), the most common form of an inherited hematological disorder, is caused by a genetic variant that leads to the synthesis of an abnormal hemoglobin, HbS.Deoxygenated HbS tends to polymerize which results in a distortion of the red blood cell shape causing vaso-occlusion and end-organ damage.The most severe forms of SCD are homozygous HbSS and HbSβ 0 -thalassemia.The latter is characterized by compound heterozygosity for HbS and a non-functional beta-thalassemia gene.Milder forms of SCD include compound heterozygous conditions, such as HbSC.SCD is a systemic disease, associated with episodes of acute illness and chronic solid organ damage, including SCD lung disease. 1 Prior to therapy with hydroxycarbamide, also called hydroxyurea (HU), in SCD HbSS untreated children suffered from severe and progressive SCD lung disease with annualized declines in pulmonary function testing (PFT) similar to cystic fibrosis.2 Male sex was associated with a more rapid PFT decline in HbSS children not treated with HU, and HbSC genotype was associated with less lung disease compared to HbSS. 2HU is a disease-modifying agent that increases HbF production, total hemoglobin concentration, as well as red blood cell survival, and has been used for SCD therapy for decades.In adults, HU therapy results in a remarkable reduction in morbidity and mortality.3 An earlier, preliminary study in a small pediatric cohort had suggested that HU therapy in SCD children may lead to improvement in PFT decline.4 However, longitudinal data on lung disease progression and risk factors associated with PFT decline in current, larger pediatric cohorts of SCD HbSS treated with HU or HbSC are lacking.The aim of this study therefore was to quantify lung disease progression in a large cohort of SCD HbSS children treated with HU according to current guidelines, and to analyze the potential effects of sex on lung function decline in children with HbSS or HbSC.Longitudinal PFT results were analyzed in a cohort of children with SCD treated at the Hospital for Sick Children, Toronto, Canada, between 1997 and 2022.The study was approved by the local Research Ethics Board (REB# 1000078457).Patients with either HbSS or with HbSC and 5 to 18 years of age attending SCD outpatient clinic who performed PFT as part of routine clinical care were included.Patients were identified by searching the respiratory medicine PFT database for a physician diagnosis of " sickle cell disease" or

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.004
GPT teacher head0.216
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueAmerican Journal of HematologySame topicHemoglobinopathies and Related DisordersFrench-language works237,207